155 related articles for article (PubMed ID: 31874201)
1. Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.
Hardisty JF; Harris SB; Hayes WA; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104555. PubMed ID: 31874201
[TBL] [Abstract][Full Text] [Related]
2. Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys.
Weber K; Häcker R; Hardisty JF; Harris SB; Hayes AW
Regul Toxicol Pharmacol; 2020 Mar; 111():104547. PubMed ID: 31816339
[TBL] [Abstract][Full Text] [Related]
3. Oral repeated-dose toxicity studies of BIA 10-2474 in Wistar rat.
Hayes AW; Hardisty JF; Harris SB; Okazaki Y; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104540. PubMed ID: 31759138
[TBL] [Abstract][Full Text] [Related]
4. Oral repeated-dose toxicity studies of BIA 10-2474 in CD-1 mice.
Hayes AW; Pressman P; Hardisty JF; Harris SB; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104557. PubMed ID: 31866343
[TBL] [Abstract][Full Text] [Related]
5. Non-clinical toxicology evaluation of BIA 10-2474.
Hayes AW; Weber K; Moser P; Soares-da-Silva P
Crit Rev Toxicol; 2021 Jan; 51(1):65-75. PubMed ID: 33528291
[TBL] [Abstract][Full Text] [Related]
6. Developmental and reproductive toxicity studies of BIA 10-2474.
Harris SB; Hardisty JF; Hayes AW; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104543. PubMed ID: 31759137
[TBL] [Abstract][Full Text] [Related]
7. Regulatory safety pharmacology evaluation of BIA 10-2474.
Hayes AW; Pressman P; Moser P; Soares-da-Silva P
J Pharmacol Toxicol Methods; 2020; 102():106677. PubMed ID: 31978535
[TBL] [Abstract][Full Text] [Related]
8. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
Rocha JF; Santos A; Gama H; Moser P; Falcão A; Pressman P; Wallace Hayes A; Soares-da-Silva P
Clin Pharmacol Ther; 2022 Feb; 111(2):391-403. PubMed ID: 33998672
[TBL] [Abstract][Full Text] [Related]
9. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
[TBL] [Abstract][Full Text] [Related]
10. Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase.
Kerbrat A; Ferré JC; Fillatre P; Ronzière T; Vannier S; Carsin-Nicol B; Lavoué S; Vérin M; Gauvrit JY; Le Tulzo Y; Edan G
N Engl J Med; 2016 Nov; 375(18):1717-1725. PubMed ID: 27806235
[TBL] [Abstract][Full Text] [Related]
11. Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.
Mao Y; Zhang X; Li L; Yuan B; Lu G
Regul Toxicol Pharmacol; 2008 Feb; 50(1):75-86. PubMed ID: 18039554
[TBL] [Abstract][Full Text] [Related]
12. The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474.
Hayes AW; Hardisty JF; Harris SB; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104556. PubMed ID: 31866344
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
[TBL] [Abstract][Full Text] [Related]
14. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in beagle dogs.
Teo SK; Stirling DI; Thomas SD; Evans MG; Khetani VD
Int J Toxicol; 2003; 22(3):215-26. PubMed ID: 12851154
[TBL] [Abstract][Full Text] [Related]
15. [A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Hayashi T; Hasegawa H; Tanaka G; Ohmae S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():505-26. PubMed ID: 9021659
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats.
Shankar GN; Potharaju S; Green CE
Drug Dev Res; 2014 Feb; 75(1):37-46. PubMed ID: 24648048
[TBL] [Abstract][Full Text] [Related]
17. Subchronic and chronic safety studies with genistein in dogs.
McClain RM; Wolz E; Davidovich A; Pfannkuch F; Bausch J
Food Chem Toxicol; 2005 Oct; 43(10):1461-82. PubMed ID: 15885867
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects.
Robertson DG; Breider MA; Milad MA
Toxicol Sci; 2001 Feb; 59(2):324-34. PubMed ID: 11158726
[TBL] [Abstract][Full Text] [Related]
20. 26-week repeated oral dose toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in beagle dogs.
Yimam M; Lee YC; Jia Q
Regul Toxicol Pharmacol; 2016 Jul; 78():66-77. PubMed ID: 27125835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
